A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Dahlin, Jayme L ^a,b   Sinville, Rondedrick ^c   Solberg, Jonathan ^c   Zhou, Hui ^a   Han, Junhong ^a   Francis, Subhashree ^c   Strasser, Jessica M ^c   John, Kristen ^c   Hook, Derek J ^c   Walters, Michael A ^c   Zhang, Zhiguo ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CANDIDA ALBICANS; CELL-FREE SYSTEM; DROSOPHILA; DROSOPHILA PROTEINS; ENZYME INHIBITORS; FUNGAL PROTEINS; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS;

EID: 84894171094     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078877     Document Type: Article

References (98)

1. Kouzarides T (2007) Chromatin modifications and their function. Cell 128: 693-705.
2. Li B, Carey M, Workman JL (2007) The role of chromatin during transcription. Cell 128: 707-719. (Pubitemid 46273570)
3. Masumoto H, Hawke D, Kobayashi R, Verreault A (2005) A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature 436: 294-298. (Pubitemid 41021284)
4. Tsubota T, Berndsen CE, Erkmann JA, Smith CL, Yang L, et al. (2007) Histone H3-K56 acetylation is catalyzed by histone chaperone-dependent complexes. Mol Cell 25: 703-712. (Pubitemid 46341923)
5. Han J, Zhou H, Horazdovsky B, Zhang K, Xu R, et al. (2007) Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication. Science 315: 653-655. (Pubitemid 46214710)
6. Driscoll R, Hudson A, Jackson SP (2007) Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56. Science 315: 649-652. (Pubitemid 46214709)
7. Chen CC, Carson JJ, Feser J, Tamburini B, Zabaronick S, et al. (2008) Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair. Cell 134: 231-243. (Pubitemid 352010334)
8. Li Q, Zhou H, Wurtele H, Davies B, Horazdovsky B, et al. (2008) Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell 134: 244-255. (Pubitemid 352010333)
9. Das C, Lucia M, Hansen K, Tyler J (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459: 113-117.
10. Tjeertes J, Miller K, Jackson S (2009) Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J 28: 1878-1889.
11. Tang Y, Holbert M, Wurtele H, Meeth K, Rocha W, et al. (2008) Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol 15: 738-745. (Pubitemid 351932005)
12. Wang L, Tang Y, Cole PA, Marmorstein R (2008) Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr Opin Struct Biol 18: 741-747.
13. Stavropoulos P, Nagy V, Blobel G, Hoelz A (2008) Molecular basis for the autoregulation of the protein acetyl transferase Rtt109. P Natl Acad Sci USA 105: 12236-12241.
14. Albaugh BN, Arnold KM, Lee S, Denu JM (2011) Autoacetylation of the histone acetyltransferase Rtt109. J Biol Chem 286: 24694-24701.
15. Berndsen CE, Tsubota T, Lindner SE, Lee S, Holton JM, et al. (2008) Molecular functions of the histone acetyltransferase chaperone complex Rtt109-Vps75. Nat Struct Mol Biol 15: 948-956.
16. Han J, Zhou H, Li Z, Xu R, Zhang Z (2007) Acetylation of lysine 56 of histone H3 catalyzed by Rtt109 and regulated by Asf1 is required for replisome integrity. J Biol Chem 282: 28587-28596. (Pubitemid 47606001)
17. Han J, Zhou H, Li Z, Xu RM, Zhang Z (2007) The Rtt109-Vps75 histone acetyltransferase complex acetylates non-nucleosomal histone H3. J Biol Chem 282: 14158-14164. (Pubitemid 47100408)
18. Lin C, Yuan YA (2008) Structural insights into histone H3 lysine 56 acetylation by Rtt109. Structure 16: 1503-1510.
19. Tang Y, Holbert MA, Delgoshaie N, Wurtele H, Guillemette B, et al. (2011) Structure of the Rtt109-AcCoA/Vps75 complex and implications for chaper-one-mediated histone acetylation. Structure 19: 221-231.
20. Guillemette B, Drogaris P, Lin H-HS, Armstrong H, Hiragami-Hamada K, et al. (2011) H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet 7: e1001354.
21. Fillingham J, Recht J, Silva A, Suter B, Emili A, et al. (2008) Chaperone control of the activity and specificity of the histone H3 acetyltransferase Rtt109. Mol Cell Biol 28: 4342-4353. (Pubitemid 351904956)
22. Burgess RJ, Zhou H, Han J, Zhang Z (2010) A role for Gcn5 in replication-coupled nucleosome assembly. Mol Cell 37: 469-480.
23. Abshiru N, Ippersiel K, Tang Y, Yuan H, Marmorstein R, et al. (2012) Chaperone-mediated acetylation of histones by Rtt109 identified by quantitative proteomics. J Proteomics 81: 80-90.
24. Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100: 4358-4366. (Pubitemid 35429674)
25. Marr KA, Carter RA, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 909-917. (Pubitemid 34229758)
26. Cornely OA, Ullmann AJ, Karthaus M (2003) Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies. Blood 101: 3365-3372. (Pubitemid 36857916)
27. Odds FC, Brown AJ, Gow NA (2003) Antifungal agents: mechanisms of action. Trends Microbiol 11: 272-279. (Pubitemid 36725017)
28. Kontoyiannis D, Lewis R (2002) Antifungal drug resistance of pathogenic fungi. Lancet 359: 1135-1144. (Pubitemid 34270742)
29. Einsele H, Loeffler J (2008) Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients. Clin Microbiol Infect 14: 37-45. (Pubitemid 351593915)
30. Jones B, McLinktock L (2003) Impact of diagnostic markers on early antifungal therapy. Curr Opin Infect Dis 16: 521-526.
31. Cottier F, Pavelka N (2012) Complexity and dynamics of host-fungal interactions. Immunol Res 53: 127-135.
32. Collette J, Lorenz M (2011) Mechanisms of immune evasion in fungal pathogens. Curr Opin Microbiol 14: 668-675.
33. Albaugh BN, Kolonko EM, Denu JM (2010) Kinetic mechanism of the Rtt109-Vps75 histone acetyltransferase-chaperone complex. Biochemistry 49: 6375-6385.
34. Wurtele H, Tsao S, Lépine G, Mullick A, Tremblay J, et al. (2010) Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med 16: 774-780.
35. Rosa JLd, Boyartchuk VL, Zhu LJ, Kaufman PD (2010) Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis. P Natl Acad Sci USA 107: 1594-1599.
36. Kottom TJ, Han J, Zhang Z, Limper AH (2011) Pneumocystis carinii expresses an active Rtt109 histone acetyltransferase. Am J Resp Cell Mol Biol 44: 768-776.
37. Pupaibool J, Kottom TJ, Bouchonville K, Limper AH (2013) Characterization of the Pneumocystis carinii histone acetyltranferase chaperone proteins PcAsf1 and PcVps75. Infect Immun 81: 2268-2275.
38. Rosa JLd, Bajaj V, Spoonamore J, Kaufman PD (2013) A small molecule inhibitor of fungal histone acetyltransferase Rtt109. Bioorg Med Chem Lett 23: 2853-2859.
39. Sippel TO (1981) New fluorochromes for thiols: maleimide and iodoacetamide derivatives of a 3-phenylcoumarin fluorophore. J Histochem Cytochem 29: 314-316.
40. Trievel RC, Li FY, Marmorstein R (2000) Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor. Anal Biochem 287: 319-328. (Pubitemid 32006243)
41. Chung CC, Ohwaki K, Schneeweis JE, Stec E, Varnerin JP, et al. (2008) A fluorescence-based thiol quantification assay for ultra-high-throughput screening for inhibitors of coenzyme A production. Assay Drug Dev Technol 6: 361-374.
42. Wang R, Ibáñez G, Islam K, Zheng W, Blum G, et al. (2011) Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors. Mol Biosyst 7: 2970-2981.
43. Linsky T, Fast W (2011) A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1. J Biomol Screen 16: 1089-1097.
44. McDonald PR, Roy A, Chaguturu R (2011) The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology. Future Med Chem 3: 1101-1110.
45. Levenstein M, Kadonaga J (2002) Biochemical analysis of chromatin containing recombinant Drosophila core histones. J Biol Chem 277: 8749-8754. (Pubitemid 34968343)
46. Su D, Hu Q, Zhou H, Thompson JR, Xu RM, et al. (2011) Structure and histone binding properties of the Vps75-Rtt109 chaperone-lysine acetyltransferase complex. J Biol Chem 286: 15625-15629.
47. Bradford M (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
48. Inglese J, Shamu CE, Guy RK (2007) Reporting data from high-throughput screening of small-molecule libraries. Nat Chem Biol 3: 438-441. (Pubitemid 47080377)
49. Miki T, Orii Y (1985) The reaction of horseradish peroxidase with hydroperoxides derived from Triton X-100. Anal Biochem 146: 28-34.
50. Zhang J, Chung T, Oldenburg K (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67-73. (Pubitemid 29278954)
51. Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53: 2719-2740.
52. Bulfer S, McQuade T, Larsen M (2011) Application of a high-throughput fluorescent acetyltransferase assay to identify inhibitors of homocitrate synthase. Anal Biochem 410: 133-140.
53. 2 by redox cycling in reducing environments. Assay Drug Dev Technol 8: 152-174.
54. Mirković B, Sosič I, Gobec S, Kos J (2011) Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety. PLoS ONE 6: e27197.
55. Feng BY, Shoichet BK (2006) A detergent-based assay for the detection of promiscuous inhibitors. Nat Protoc 1: 550-553.
56. McGovern S, Helfand B, Feng B (2003) A specific mechanism of nonspecific inhibition. J Med Chem 46: 4265-4272. (Pubitemid 37153008)
57. Berndsen CE, Denu JM (2005) Assays for mechanistic investigations of protein/histone acetyltransferases. Methods 36: 321-331. (Pubitemid 41188062)
58. Yang J, Copeland RA, Lai Z (2009) Defining balanced conditions for inhibitor screening assays that target bisubstrate enzymes. J Biomol Screen 14: 111-120.
59. Falk H, Connor T, Yang H, Loft KJ, Alcindor JL, et al. (2011) An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets. J Biomol Screen 16: 1196-1205.
60. Gao T, Yang C, Zheng YG (2012) Comparative studies of thiol-sensitive fluorogenic probes for HAT assays. Anal Bioanal Chem 421: 1-11.
61. Seidler J, McGovern SL, Doman TN, Shoichet BK (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 46: 4477-4486. (Pubitemid 37238749)
62. Feng BY, Simeonov A, Jadhav A, Babaoglu K, Inglese J, et al. (2007) A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem 50: 2385-2390. (Pubitemid 46799249)
63. Ryan AJ, Gray NM, Lowe PN, Chung C-w (2003) Effect of detergent on "promiscuous" inhibitors. J Med Chem 46: 3448-3451.
64. McGovern SL, Caselli E, Grigorieff N, Shoichet BK (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 45: 1712-1722. (Pubitemid 34293537)
65. Malo N, Hanley JA, Cerquozzi S, Pelletier J, Nadon R (2006) Statistical practice in high-throughput screening data analysis. Nat Biotech 24: 167-175. (Pubitemid 43221699)
66. Gubler H (2006) Methods for statistical analysis, quality assurance and management of primary high-throughput screening data. In: Hüser J, editor. High-Throughput Screening in Drug Discovery. KGaA, Weinheim, FRG: Wiley-VCH Verlag GmbH & Co.
67. Kevorkov D, Makarenkov V (2005) Statistical analysis of systematic errors in high-throughput screening. J Biomol Screen 10: 557-567. (Pubitemid 41306653)
68. Brideau C, Gunter B, Pikounis B, Liaw A (2003) Improved statistical methods for hit selection in high-throughput screening. J Biomol Screen 8: 634-647.
69. Balasubramanyam K, Altaf M, Varier R, Swaminathan V, Ravindran A, et al. (2004) Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 279: 33716-33726. (Pubitemid 39063021)
70. Arif M, Pradhan SK, Thanuja GR, Vedamurthy BM, Agrawal S, et al. (2009) Mechanism of p300 specific histone acetyltransferase inhibition by small molecules. J Med Chem 52: 267-277.
71. Huth JR, Mendoza R, Olejniczak ET, Johnson RW, Cothron DA, et al. (2005) ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc 127: 217-224. (Pubitemid 40094385)
72. Sleno L, Staack RF, Varesio E, Hopfgartner G (2007) Investigating the in vitro metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 21: 2301-2311. (Pubitemid 47121162)
73. Dietrich LEP, Teal TK, Price-Whelan A, Newman DK (2008) Redox-active antibiotics control gene expression and community behavior in divergent bacteria. Science 321: 1203-1206.
74. Bova MP, Mattson MN, Vasile S, Tam D, Holsinger L, et al. (2004) The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase alpha is mediated by hydrogen peroxide. Arch Biochem Biophys 429: 30-41. (Pubitemid 39013380)
75. Sang S, Liao C-H, Pan M-H, Rosen RT, Lin-Shiau S-Y, et al. (2002) Chemical studies on antioxidant mechanism of garcinol: analysis of radical reaction products of garcinol with peroxyl radicals and their antitumor activities. Tetrahedron 58: 10095-10102. (Pubitemid 35447793)
76. Baell JB (2010) Observations on screening-based research and some concerning trends in the literature. Future Med Chem 2: 1529-1546.
77. D'Arcy S, Luger K (2011) Understanding histone acetyltransferase Rtt109 structure and function: how many chaperones does it take? Curr Opin Struc Biol 21: 1-7.
78. Zhen Z, Tang L-J, Long H, Jiang J-H (2012) Enzymatic immuno-assembly of gold nanoparticles for visualized activity screening of histone-modifying enzymes. Anal Chem 84: 3614-3620.
79. Copeland RA (2003) Mechanistic considerations in high-throughput screening. Anal Biochem 320: 1-12.
80. Shoichet BK (2006) Interpreting steep dose-response curves in early inhibitor discovery. J Med Chem 49: 7274-7277.
81. Aherne GW, Rowlands MG, Stimson L, Workman P (2002) Assays for the identification and evaluation of histone acetyltransferase inhibitors. Methods 26: 245-253. (Pubitemid 34969566)
82. Ait-Si-Ali S, Ramirez S, Robin P, Trouche D, Harel-Bellan A (1998) A rapid and sensitive assay for histone acetyl-transferase activity. Nucleic Acids Res 26: 3869-3870. (Pubitemid 28367999)
83. Tanner KG, Tievel RC, Kuo MH, Howard RM, Berger SL, et al. (1999) Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase Gcn5 transcriptional coactivator. J Biol Chem 274: 18157-18160.
84. Turlais F, Hardcastle A, Rowlands M, Newbatt Y, Bannister A, et al. (2001) High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate). Anal Biochem 298: 62-68. (Pubitemid 33030122)
85. Fanslau C, Pedicord D, Nagulapalli S, Gray H, Pang S, et al. (2010) An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors. Anal Biochem 402: 65-68.
86. Kim Y, Tanner KG, Denu JM (2000) A continuous, nonradioactive assay for histone acetyltransferases. Anal Biochem 280: 308-314. (Pubitemid 30308087)
87. Davis BJ, Erlanson DA (2013) Learning from our mistakes: The 'unknown knowns' in fragment screening. Bioorg Med Chem Lett: In press.
88. Šink R, Gobec S, Pecar S (2010) False positives in the early stages of drug discovery. Curr Med Chem 17: 4231-4255.
89. Jadhav A, Ferreira RS, Klumpp C, Mott BT, Austin CP, et al. (2010) Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. J Med Chem 53: 37-51.
90. 2 in HTS buffers containing strong reducing reagents-real hits or promiscuous artifacts? Curr Opin Chem Biol 15: 174-182.
91. Lor LA, Schneck J, McNulty DE, Diaz E, Brandt M, et al. (2007) A simple assay for detection of small-molecule redox activity. J Biomol Screen 12: 881-890. (Pubitemid 47340702)
92. Metz JT, Huth JR, Hajduk PJ (2007) Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups. J Comput Aid Mol Des 21: 139-144. (Pubitemid 46416673)
93. Huang Z (2011) Impact of impurities on IC50 values of P450 inhibitors. Drug Metab Lett 5: 156-162.
94. Jaki BU, Frazblau SG, Chadwick LR, Lankin DC, Zhang F, et al. (2008) Purity-activity relationships of natural products: the case of anti-TB active ursolic acid. J Nat Prod 71: 1742-1748.
95. Hermann JC, Chen Y, Wartchow C, Menke J, Gao L, et al. (2013) Metal impurities cause false positives in high-throughput screening campaigns. ACS Med Chem Lett 4: 197-200.
96. Canny SA, Cruz Y, Southern MR, Griffin PR (2009) PubChem promiscuity: a web resource for gathering compound promiscuity data from PubChem. Bioinformatics 28: 140-141.
97. Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009. (Pubitemid 350273630)
98. Cole PA (2008) Chemical probes for histone-modifying enzymes. Nat Chem Biol 4: 590-597.